Veriff, a global identity verification and authentication platform, offers some early findings from its 2025 Identity Fraud Report. It shows a 21% increase in fraud attempts and unveils new ...
Andrew Fein has given his Buy rating due to a combination of factors that highlight the unique positioning of Acumen Pharmaceuticals in the Alzheimer’s treatment landscape. A key differentiator for ...